Cargando…
Rapid Detection of Anti-SARS-CoV-2 Antibody Using a Selenium Nanoparticle-Based Lateral Flow Immunoassay
Coronavirus disease 2019 is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is highly transmissible. Early and rapid testing is necessary to effectively prevent and control the outbreak. Detection of SARS-CoV-2 antibodies with lateral flow...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
IEEE
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905607/ https://www.ncbi.nlm.nih.gov/pubmed/34406945 http://dx.doi.org/10.1109/TNB.2021.3105662 |
Ejemplares similares
-
An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies
por: Spicuzza, Lucia, et al.
Publicado: (2023) -
Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies
por: Montesinos, Isabel, et al.
Publicado: (2020) -
Ultrabright nanoparticle-labeled lateral flow immunoassay for detection of anti-SARS-CoV-2 neutralizing antibodies in human serum
por: Bian, Lun, et al.
Publicado: (2022) -
Rapid detection of SARS-CoV-2: The gradual boom of lateral flow immunoassay
por: He, Jing, et al.
Publicado: (2023) -
Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies
por: Owen, Sophie I., et al.
Publicado: (2022)